|
WO2021039883A1
|
|
Prediction method and prediction device
|
|
WO2020218496A1
|
|
Measurement device, measurement method, and radiation projecting device
|
|
WO2020218499A1
|
|
Fetal rhd blood type detection kit and use thereof
|
|
WO2020166707A1
|
|
Processing device, determination method, control program, and recording medium
|
|
US2019360031A1
|
|
Method of amplifying a polynucleotide of interest
|
|
WO2019131938A1
|
|
Method for preparing functional liver progenitor cells or liver cells, or preparing functional small-intestinal epithelial progenitor cells or small-intestinal epithelial cells
|
|
WO2019124267A1
|
|
Test method for diagnosis of niemann-pick disease type c
|
|
WO2019088164A1
|
|
Novel polynucleotide and utilization thereof
|
|
TW201912786A
|
|
Method for evaluating TREC or KREC level, particles used in said method, and use thereof
|
|
WO2018164275A1
|
|
Antisense oligonucleotide and composition for prevention or treatment of glycogen storage disease type ia
|
|
US2018214494A1
|
|
Method and composition for preventing egg allergy
|
|
WO2018043715A1
|
|
Examination method and examination kit for eosinophilic gastrointestinal disease or food-protein induced enteropathy
|
|
US2017191033A1
|
|
Method for preparation of retinal ganglion cells
|
|
EP2835424A1
|
|
DNA CONTROLLING miR-140 EXPRESSION, AND SCREENING METHOD OF DRUGS USING SAID DNA
|
